PSP5:PA:PA-Lyxor PEA S&P 500 UCITS C (EUR)

ETF | Others |

Last Closing

USD 48.941

Change

-0.97 (-1.95)%

Market Cap

USD 0.76B

Volume

0.10M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.86%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-10.50 (-1.83%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-7.62 (-1.85%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.56 (-1.52%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.12 (-0.05%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-14.30 (-2.84%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-5.44 (-1.50%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-1.05 (-1.81%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.13 (+1.68%)

USD 5.25B

ETFs Containing PSP5:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.02% 18% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.02% 17% F 29% F
Trailing 12 Months  
Capital Gain 21.91% 86% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.91% 84% B 83% B
Trailing 5 Years  
Capital Gain 116.47% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 116.47% 94% A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 18.83% 88% B+ 83% B
Dividend Return 18.83% 92% A 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.22% 68% D+ 80% B-
Risk Adjusted Return 123.72% 97% N/A 98% N/A
Market Capitalization 0.76B 74% C 76% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike